Related Experiment Video
Updated: Feb 22, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Fetal and Infant Growth Patterns and Risk of Lower Lung Function and Asthma. The Generation R Study
Herman T den Dekker1,2,3, Vincent W V Jaddoe1,3,4, Irwin K Reiss5
11 Generation R Study Group.
Insights
Fetal and infant growth patterns significantly impact childhood lung function, with restricted or accelerated growth linked to reduced lung capacity. However, neither pattern was associated with childhood asthma development.
Area of Science:
- Pediatric respiratory health
- Growth and development studies
- Epidemiology
Background:
- Lower birth weight in children is a known risk factor for developing asthma symptoms.
- Understanding the impact of fetal and infant growth on long-term respiratory health is crucial for early intervention.
Purpose of the Study:
- To investigate the association between fetal and infant growth trajectories and lung function at age 10.
- To determine if fetal and infant growth patterns are linked to the incidence of childhood asthma.
Main Methods:
- A prospective cohort study of 5,635 children, with growth assessed via ultrasounds and measurements at birth and up to 12 months.
- Lung function (FEV1, FVC, FEF75%) measured at age 10 using spirometry; asthma assessed via parental questionnaire.
- Statistical analyses included multiple and conditional regression to evaluate growth percentile changes (restricted/accelerated) and their impact on lung function and asthma.
Main Results:
- Greater fetal and early infant weight was associated with higher FEV1 and FVC, but later infant weight gain (3 months) correlated with lower FEV1/FVC and FEF75%.
- Restricted fetal growth was linked to reduced childhood lung function, with effects modified by infant growth patterns.
- Accelerated fetal growth, particularly when followed by accelerated infant growth, was associated with higher FVC but lower FEV1/FVC.
Conclusions:
- Both restricted and accelerated fetal and infant weight growth patterns can negatively affect lung function development in children.
- These growth deviations may predispose children to respiratory diseases later in life, highlighting the importance of monitoring fetal and infant growth.
- No significant association was found between fetal and infant weight growth patterns and the development of childhood asthma.
Rationale:
Children with lower birth weight are at increased risk of asthma symptoms.
Objectives:
To examine associations of fetal and infant growth with childhood lung function and asthma.
Methods:
This study was embedded in a population-based prospective cohort study of 5,635 children. Growth was estimated by repeated ultrasounds in the second and third trimesters, and measured at birth and at 3, 6, and 12 months. At age 10 years, spirometry was performed and asthma was assessed by parental questionnaire. Restricted and accelerated growth were defined as the growth percentile change between time periods less than -0.67 and more than 0.67 SD scores (SDSs), respectively. We applied multiple regression analyses, including conditional regression analyses, to account for correlations between repeated growth measures.
Measurements And Main Results:
Overall greater weight in the second and third trimesters, at birth, and at 12 months was associated with higher FEV1 and FVC (range of z-score difference, 0.04-0.08, per SDS increase in weight). Greater weight at 3 months was associated with lower FEV1/FVC and forced expiratory flow at 75% of the pulmonary volume (FEF75%) (z-score differences [95% confidence interval]: -0.09 [-0.14 to -0.05] and -0.09 [-0.13 to -0.05] per SDS increase in weight, respectively). Restricted fetal weight growth was associated with lower childhood lung-function measures, partly depending on infant weight growth patterns (range of z-score difference, -0.25 to -0.13). Accelerated fetal weight growth was associated with higher FVC and lower FEV1/FVC only if followed by accelerated infant weight growth. Fetal and infant weight growth was not associated with childhood asthma.
Conclusions:
Both restricted fetal weight growth, partly depending on infant weight growth, and accelerated fetal and infant weight growth predispose children to lower lung function and a potential risk for respiratory diseases later in life.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-I: Introduction
Breathing
Nature and Nurture
Teratogenicity
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

